Rising FistRising Fist🃏All Jynx cards
Ask about Jynx
Jynx #35 Pokémon card from Japanese Rising Fist
Japanese

Jynx 35/96

Rising Fist· Language: Japanese

👁 Watch📊 Add to portfolioFree — no card required to register.
Find this card on eBay

Affiliate link · we may earn commission

Jynx #35 from Japanese Rising Fist currently trades at $3.13 raw, with PSA 10 copies reaching $41.03 — a 13.1x grade premium.
Current Prices (USD)
Ungraded
$3.13
PSA 7
$41.03
PSA 8
$41.03
PSA 9
$41.03
PSA 10
$41.03
ACE 10
BGS 10 Black
$265.00
CGC 10 Pristine
$45.00
Compare on eBay

Affiliate link · we may earn commission

Raw Price Trend
7d
30d
90d
180d
+12.6%
1y
-21.8%
2y
+6.8%
5y

Quick price facts

Jynx 35/96 from Rising Fist has a current raw market value of $3.13.

Current raw value
$3.13
PSA 9 value
$41.03
PSA 10 value
$41.03
PSA 10 premium vs raw
13.1× raw
View all cards from Rising Fist
Collector Intel
13.1x
Raw → PSA 10
High-risk grade
13.1x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

$3
Buy Raw
~$25
Grading Fee
PSA Standard
$41
PSA 10 Value
+$13
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$4113.1x raw
PSA 10$4113.1x raw

Frequently asked questions

How much is Jynx #35 from Japanese Rising Fist worth?+
Jynx #35 from Japanese Rising Fist is currently worth Raw: $3.13, PSA 9: $41.03, PSA 10: $41.03 based on recent sold listings. Prices update daily from real eBay sales.
Is Jynx #35 worth grading?+
The PSA 10 price of $41.03 is 13.1× the raw price of $3.13. After a ~$25 grading fee, a PSA 10 result would net approximately $37.90 — assuming the card grades a 10.
Where do PokePrices Jynx #35 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.